Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...

EST Cathie Wood’s ARK Investment buys 250K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.

Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive ...

Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.

Jan. 30, 2025 Cathie Wood-led Ark Invest sold $10.4 million worth of Palantir shares through its flagship fund.

Cathie Wood's ARK ETFs have made their daily trades for Tuesday, January 28th, 2025, with significant activity across various sectors, particularly in technology and biotech. The trades reflect a ...

Cathie Wood's ARK ETFs have made their daily trades for Tuesday, January 28th, 2025, with significant activity across various sectors, particularly in technology and biotech. The trades reflect a ...

Cathie Wood bounced back in 2024. The growth investor who rocked the world in 2020 with her market-thumping returns at Ark Invest has proved to be mortal in subsequent years. However, a couple of ...

according to Cathie Wood, Chief Executive Officer at Ark Investment Management. DeepSeek’s new open-source AI model, widely seen as a challenge to US dominance in the tech industry, caused a 3% ...